For the year ending 2025-12-31, ARMP made $4,904K in revenue. -$173,799K in net income. Net profit margin of -3544.03%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Grant and award revenue | 4,904 | |||
| Research and development | 23,717 | |||
| General and administrative | 12,409 | |||
| Impairment expense | 5,412 | |||
| Total operating expenses | 41,538 | |||
| Operating loss | -36,634 | |||
| Interest income | 388 | |||
| Interest expense | 16,590 | |||
| Change in fair value of the convertible loan | -120,963 | |||
| Total other income (expense), net | -137,165 | |||
| Net loss | -173,799 | |||
| Basic EPS | -4.8 | |||
| Diluted EPS | -4.8 | |||
| Basic Average Shares | 36,239,253 | |||
| Diluted Average Shares | 36,239,253 | |||
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP)